share_log

BioVie: BioVie Inc. - Reverse Split Option Symbol: BIVI New Symbol: BIVI1

BioVie: BioVie Inc. - Reverse Split Option Symbol: BIVI New Symbol: BIVI1

BioVie：BioVie公司 - 反向拆股标的: BIVI 新标的: BIVI1
OCC期权清算公司 ·  2024/08/02 14:18

Moomoo AI 已提取核心信息

BioVie Inc. (BIVI) has announced a reverse stock split that is scheduled to take effect before the market opens on August 6, 2024. The reverse split will be conducted at a ratio of 1-for-10, meaning that each Class A Common Share of BioVie will be converted into 0.1 of a new Class A Common Share. Following the split, the option symbol for BioVie will change from BIVI to BIVI1. The new CUSIP number for the post-split shares will be 09074F405. The pricing for the new BIVI1 option will be set at 0.10 times the price of the current BIVI option. The Options Clearing Corporation (OCC) has provided this information and will be responsible for the adjustments to options and futures as per their by-laws.
BioVie Inc. (BIVI) has announced a reverse stock split that is scheduled to take effect before the market opens on August 6, 2024. The reverse split will be conducted at a ratio of 1-for-10, meaning that each Class A Common Share of BioVie will be converted into 0.1 of a new Class A Common Share. Following the split, the option symbol for BioVie will change from BIVI to BIVI1. The new CUSIP number for the post-split shares will be 09074F405. The pricing for the new BIVI1 option will be set at 0.10 times the price of the current BIVI option. The Options Clearing Corporation (OCC) has provided this information and will be responsible for the adjustments to options and futures as per their by-laws.
BioVie公司 (BIVI) 宣布进行股票拆分，拆分比例为 1股合并为10股，将在2024年8月6日市场开盘前生效，意味着每股BioVie A类普通股将转换为0.1股新的A类普通股。拆分后，BioVie的期权标的符号将从BIVI更改为BIVI1。拆分后股票的新CUSIP编号是09074F405。新BIVI1期权的定价将设置为当前BIVI期权价格的0.1倍。期权结算所OCC已经提供了此信息，并将根据其章程对期权和期货进行调整。
BioVie公司 (BIVI) 宣布进行股票拆分，拆分比例为 1股合并为10股，将在2024年8月6日市场开盘前生效，意味着每股BioVie A类普通股将转换为0.1股新的A类普通股。拆分后，BioVie的期权标的符号将从BIVI更改为BIVI1。拆分后股票的新CUSIP编号是09074F405。新BIVI1期权的定价将设置为当前BIVI期权价格的0.1倍。期权结算所OCC已经提供了此信息，并将根据其章程对期权和期货进行调整。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Neuphoria Therapeutics
    NEUP
    -- 8.200
    PMGC Holdings
    ELAB
    -- 3.289
    Evaxion Biotech
    EVAX
    -- 5.950
    Lantern Pharma
    LTRN
    -- 5.670
    Transcode Therapeutics
    RNAZ
    -- 6.875
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球股市新风口在哪里？
    ▪️加密货币政策能否利好crypto？ ▪️关税政策能否利好中概等海外资产？ ▪️在特朗普政策下，有哪些投资机会值得关注？ 展开
    离川普上台只有7天了～
    热门中概股
    追踪最热门的中概股实时资讯。